Bleeding Monitoring Methods using anesthesia

Received: 06-Sep-2022, Manuscript No. pulacr-22-5568; Editor assigned: 07-Sep-2022, Pre QC No. pulacr-22-5568 (PQ); Accepted Date: Sep 26, 2022; Reviewed: 21-Sep-2022 QC No. pulacr-22-5568 (Q); Revised: 23-Sep-2022, Manuscript No. pulacr-22-5568 (R); Published: 27-Sep-2022, DOI: 10.37532.pulacr-22.5.5.6-8

Citation: Yadav V. Bleeding monitoring methods. Anesthesiol Case Rep. 2022;5(5):6-8.

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@pulsus.com

Abstract

One factor that may be avoided that contributes to patient deaths after major surgery is bleeding. To accomplish the best resuscitation, appropriate monetarization is required. However, there are several restrictions on traditional coagulation tests. Point-of-care (POC) assays have been developed recently to increase patient safety when there is clinical bleeding. POC assays assess the viscoelastic characteristics of full-thickness clot formation at the onset of bleeding.

Keywords

Coagulation; Bleeding; Platelets count; Thrombin; Platelet aggregation; Fibrin strands

Introduction

One of the most dreaded side effects is bleeding, particularly in patients undergoing concurrent anesthesia and extensive surgical procedures [1,2]. The most popular techniques for determining a patient's coagulation status are routine laboratory coagulation testing and platelet count assessment. Conventional testing has some limitations, though; point-of-care (POC) tests were created to get around these restrictions [2].

Reduced rates of morbidity and death are the primary objectives of anesthesiologists, along with the prevention of hemostasis deterioration brought on by bleeding and bleeding complications [3,4]. Platelet dysfunction, excessive fibrinolysis, hypothermia, preoperative anemia, a deficiency in coagulation factors, or dilution are some of the potential reasons for perioperative bleeding. Hyperfibrinolysis is one of those and also the main contributor to the emergence of post-traumatic coagulopathy [3,4]. Bleeding monitoring is crucial for patient-specific transfusion planning and to prevent the unfavorable consequences of excess volume; otherwise, unnecessary allogeneic blood transfusions would increase perioperative problems and hazards [5]. Although there isn't a management strategy that is universally approved for treating bleeding patients, algorithm-based transfusion regimens that rely on POC testing yield better outcomes than individual choices [6].

The patient's history of bleeding and laboratory testing should be used in bleeding monitoring to identify elevated bleeding risk, but external factors cannot be completely ruled out [7]. The amount of platelet, activated partial thromboplastin time (a PTT), prothrombin time (PT), and fibrinogen levels should be assessed, according to guidelines for the management of bleeding monetarization [3].

Coagulation Cascade

The cell-based coagulation cascade model is made up of numerous intricate biochemical and cellular processes. Routine plasmabased coagulation tests, however, do not account for the cellular component of coagulation, making them insufficient to address bleeding issues [4]. The anesthetic practitioner must give excellent care prior to, during, and following a procedure in order to prevent potentially deadly complications in a patient with a clotting disease. The tissue factor is released to start the extrinsic route, which then activates the FVII to make Factor (F)X active. The intrinsic pathway starts as a result of injury to the blood vessels, whereas the extrinsic pathway is initiated following tissue damage. The intrinsic pathway first activates factor XII, which is released once blood contacts the surface of the injured vessel, and then activates the FX, which then activates FXI and FIX.

FX activation enables access to the common route. Thrombin enters the circuit in this manner. Prothrombin transforms into thrombin upon FX activation, which then affects the fibrin. Thrombin also activates FXIII, which results in the development of cross-linked fibrin strands.

FX activation enables access to the common route. Thrombin enters the circuit in this manner. Prothrombin transforms into thrombin upon FX activation, which then affects the fibrin. Thrombin also activates FXIII, which results in the development of cross-linked fibrin strands.

Standard-Bedside Coagulation Tests

Prothrombin time and activated partial thromboplastin time, two common laboratory assays, only use the patient's plasma to produce their results and do not take platelets or fibrin into account [5]. Even though tests like platelet count, platelet aggregation, Clauss fibrinogen measures, and fibrin degradation products can evaluate specific components of coagulation, they do not account for interactions in blood or the contributions of the cellular content [8,9]. These don't entail multifactorial states like endothelial influences on clot formation, platelet interactions that lead to thrombin production and fibrinolysis, or interactions between platelets. These tests, which can be used to forecast transfusion and mortality, are available from numerous laboratories [9].

The practice of anesthesia professionals requires them to provide a preoperative medical evaluation on patients who have coagulation disorders. In order to ascertain whether a coagulation issue occurs, the anesthesia practitioner first must ask each patient about their surgical and medical backgrounds.

Standard laboratory procedures are time-consuming and unhelpful, taking nearly 45 minutes to get findings, especially for trauma patients who require quick assessments in the initial hours [10]. On the other hand, within 5 minutes–10 minutes, bedside viscoelastic testing can offer a qualitative assessment of patients' coagulation status. Standard diagnostics cannot detect hyperfibrinolysis situations. However, trauma victims' hyperfibrinolysis is linked to a poor prognosis [3,10]. Traditional assays fall short of identifying acquired pro- and anticoagulant deficits brought on by thrombomodulin [1].

Platelet Function Monitoring

In order to create and maintain stable clots, platelets and functioning fibrinogen are both required. To sustain hemostasis when the vascular endothelium is damaged, thrombin must be formed. It is also important for the suppression of thrombus formation when the vascular endothelin is present. As a result, fibrinogen and platelet function must be evaluated quickly because they are both necessary for the production of hemostatic clots. Although ineffectual in proving bleeding or acquired hemorrhagic disorders, platelet function tests are beneficial in monitoring inherited platelet function problems and antiplatelet medicines [11].

Limitations In Point-Of-Care Tests

TEG needs to be calibrated every day. It is advised to calibrate two or three times every day. TEG shouldn't be used by those who are not trained, even if it can be utilized with minimal laboratory instruction. As a point-of-care examination, TEG requires uniformity. Although the necessary information can be acquired in 10 minutes, the entire test takes 30 minutes to 60 minutes. It is therefore slower than conventional tests.

Any trauma to a patient who has a coagulation issue during a procedure must be avoided by the anesthesiologist since it could cause significant bleeding. Viscoelastic coagulation tests assess the condition of coagulation in a static (non-current) state in a cuvette that is not an endothelial blood vessel [2]. For this reason, when assessing these in vitro data, the clinical situation must be taken into account. Although severe bleeding after cardiopulmonary bypass may be detected by viscoelastic POC testing, the accuracy of bleeding prediction is still debatable. These instruments take a lot of time to define thrombosis, and their extended clinical use is not standardized [12].

When predicting coagulation problems in hypothermic patients, TEG and ROTEM make sure that results are obtained at 370C [8]. Point-of-care testing is less accurate and produces more inconsistent outcomes. In general, there is a scarcity of research on price performance.

Conclusion

Regular plasma-based testing might not be sufficient to show coagulopathic hemorrhage. Point-of-care tests is crucial for maximizing treatment because they guarantee that the proper substance is delivered at the right time when there is clinical bleeding. They are also useful for assessing bleeding quickly, particularly during surgery, and they can evaluate all coagulation parameters at the patient's bedside in various medical specialties. Thromboelastometry and TEG are still significant and developing fields in medicine. POC testing can be used to precisely and affordably decrease the use of blood products while monitoring the management of anticoagulants, and hyper- and hypercoagulation.

References

1. De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology 2016;63(2):566-73. [Google Scholar] [Crossref]
2. Ganter MT, Hofer CK. Coagulation monitoring: Current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106(5):1366-75. [Google Scholar] [Crossref]
3. Beynon C, Unterberg AW, Sakowitz OW. Point of care coagulation testing in neurosurgery. J Clin Neurosci 2015;22(2):252-7. [Google Scholar] [Crossref]
4. Bose E, Hravnak M. Thromboelastography: A Practice Summary for Nurse Practitioners Treating Hemorrhage. J Nurse Pract 2015;11(7):702-9. [Google Scholar] [Crossref]
5. Abdelfattah K, Cripps MW. Thromboelastography and Rotational Thromboelastometry use in trauma. Int J Surg 2016;33:196-201. [Google Scholar] [Crossref]
6. Besser MW, Ortmann E, Klein AA. Haemostatic management of cardiac surgical haemorrhage. Anaesthesia. 2015;70:87-e31. [Google Scholar] [Crossref]
7. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anesthesiology. Eur J Anaesthesiol 2013;30(6):270-382. [Google Scholar] [Crossref]
8. Babski DM, Brainard BM, Krimer PM, et al. Sonoclot evaluation of whole blood coagulation in healthy adult dogs. J Vet Emerg Crit Care 2012;22(6):646-52. [Google Scholar] [Crossref]
9. Cap A, Hunt BJ. The pathogenesis of traumatic coagulopathy. Anesthesia 2015;70:96-e34. [Google Scholar] [Crossref]
10. Chandler WL. Emergency assessment of hemostasis in the bleeding patient. Int J Lab Hematol. 2013;35(3):339-43. [Google Scholar] [Crossref]
11. Paniccia R, Priora R, Liotta AA, et al. Platelet function tests: a comparative review. Vasc Health Risk Manag 2015;11:133-48. [Google Scholar] [Crossref]
12. Lancé MD A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 2015;13(1):1-6. [Google Scholar] [Crossref]